76
Participants
Start Date
November 23, 2015
Primary Completion Date
October 10, 2018
Study Completion Date
December 27, 2018
Palbociclib
Palbociclib oral dosing on Days 1 to 21 of each 28-day cycle.
Nab-Paclitaxel
Nab-paclitaxel IV dosing on Days -2, 6, and 13 of Cycle 1, and on Days 1, 8, and 15 of subsequent cycles.
Hospital Universitario 12 de Octubre Servicio de Farmacia, Madrid
Hospital Universitario 12 de Octubre, Madrid
Hospital Universitario de Fuenlabrada. Unidad de Farmacia, Fuenlabrada
Hospital Universitario Fuenlabrada, Fuenlabrada
Barnes-Jewish Hospital, St Louis
Washington University Infusion Center Pharmacy, St Louis
Washington University School of Medicine, St Louis
Siteman Cancer Center - South County, St Louis
Siteman Cancer Center - West County, Creve Coeur
Siteman Cancer Center, City of Saint Peters
Anschutz Cancer Pavilion, Aurora
University of Colorado Cancer Center, Aurora
University of Colorado Denver, CTO (CTRC), Aurora
University of Colorado Hospital - Anschutz Inpatient Pavilion (AIP), Aurora
University of Colorado Hospital - Anschutz Outpatient Pavilion (AOP), Aurora
University of Utah, Huntsman Cancer Hospital, Salt Lake City
University of Utah, Huntsman Cancer Institute, Salt Lake City
Scottsdale Healthcare Hospitals DBA HonorHealth, Scottsdale
Virginia G. Piper Cancer Pharmacy, Scottsdale
UC San Diego Moores Cancer Center, La Jolla
UC San Diego Medical Center - Hillcrest, San Diego
UC San Diego Medical Center - La Jolla (Thornton Hospital), La Jolla
UC San Diego Moores Cancer Center - Investigational Drug Services, La Jolla
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
Beth Israel Deaconess Medical Center, Boston
Hospital Universitari Vall D'Hebron, Servicio de Oncología Médica, Barcelona